C-peptide as an investigatory tool for endogenous insulin secretion in Type 2 diabetes mellitus patients of Mahakaushal region

Anshul Jain; Prabhat Kumar Budholia; Namrata Dubey; Rakesh Singh Gadhwal; Jyoti Arora

doi:10.5455/njppp.2023.13.03120202320032023

2024, Vol: 14, Issue: 5

14 / 5Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Online Publishing Date:
08 / 04 / 2023

Natl J Physiol Pharm Pharmacol. 2023; 13(10): 2156-2159

doi: 10.5455/njppp.2023.13.03120202320032023

C-peptide as an investigatory tool for endogenous insulin secretion in Type 2 diabetes mellitus patients of Mahakaushal region

Anshul Jain, Prabhat Kumar Budholia, Namrata Dubey, Rakesh Singh Gadhwal, Jyoti Arora.

Abstract
Background: Type 2 diabetes mellitus (T2DM) is a disease state of chronic hyperglycemia that occurs due to decrease insulin secretion or attenuated insulin response or both. Insulin resistance with relative insulin deficiency is a peculiar feature of T2DM. Proinsulin is synthesized by the beta cell of the pancreas. Before secretion into the portal vein, proinsulin cleaves into equal quantities of insulin and C-peptide. The secreted insulin gets extensively metabolized by the liver and has a shorter half-life than C-peptide. Thus, C-peptide levels more accurately perceive the endogenous insulin secretion of the pancreas. Hence, C-peptide can be used to interpret the significant pathophysiology behind T2DM.

Aims and Objectives: The aim of the study was to perceive endogenous insulin secretion or beta cell functioning of the pancreas by measuring C-peptide levels in T2DM patients.

Materials and Methods: The cross-sectional study was conducted on 120 random T2DM patients attending the outpatient clinic of tertiary care hospital (Netaji Subash Chandra Bose Medical College, Jabalpur) from January 2021 to August 2022. All T2DM patients were evaluated with fasting C-peptide levels.

Results: Among 120 cases,25 (20.8%) have low C-peptide levels of <1.1 ng/dL, indicating poor insulin reserve.33 (27.5%) have normal C-peptide levels, and approximately half −62 (51.6%) have high C-peptide levels of more than 3.3 ng/dL, indicating adequate endogenous insulin secretion and insulin resistance is the significant pathophysiology behind T2DM.

Conclusion: C-peptide level is a useful investigation to perceive endogenous insulin secretion and beta cell function of the pancreas. Insulin resistance rather than insulin deficiency is the significant pathophysiology behind T2DM.

Key words: Type 2 Diabetes Mellitus; C-peptide; Diabetes; Insulin Secretion; Beta Cell Function

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Anshul Jain Articles by Prabhat Kumar Budholia Articles by Namrata Dubey Articles by Rakesh Singh Gadhwal Articles by Jyoti Arora
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Jain A, Budholia PK, Dubey N, Gadhwal RS, Arora J. C-peptide as an investigatory tool for endogenous insulin secretion in Type 2 diabetes mellitus patients of Mahakaushal region. Natl J Physiol Pharm Pharmacol. 2023; 13(10): 2156-2159. doi:10.5455/njppp.2023.13.03120202320032023

Web Style

Jain A, Budholia PK, Dubey N, Gadhwal RS, Arora J. C-peptide as an investigatory tool for endogenous insulin secretion in Type 2 diabetes mellitus patients of Mahakaushal region. https://www.njppp.com/?mno=144978 [Access: March 15, 2024]. doi:10.5455/njppp.2023.13.03120202320032023

AMA (American Medical Association) Style

Jain A, Budholia PK, Dubey N, Gadhwal RS, Arora J. C-peptide as an investigatory tool for endogenous insulin secretion in Type 2 diabetes mellitus patients of Mahakaushal region. Natl J Physiol Pharm Pharmacol. 2023; 13(10): 2156-2159. doi:10.5455/njppp.2023.13.03120202320032023

Vancouver/ICMJE Style

Jain A, Budholia PK, Dubey N, Gadhwal RS, Arora J. C-peptide as an investigatory tool for endogenous insulin secretion in Type 2 diabetes mellitus patients of Mahakaushal region. Natl J Physiol Pharm Pharmacol. (2023), [cited March 15, 2024]; 13(10): 2156-2159. doi:10.5455/njppp.2023.13.03120202320032023

Harvard Style

Jain, A., Budholia, . P. K., Dubey, . N., Gadhwal, . R. S. & Arora, . J. (2023) C-peptide as an investigatory tool for endogenous insulin secretion in Type 2 diabetes mellitus patients of Mahakaushal region. Natl J Physiol Pharm Pharmacol, 13 (10), 2156-2159. doi:10.5455/njppp.2023.13.03120202320032023

Turabian Style

Jain, Anshul, Prabhat Kumar Budholia, Namrata Dubey, Rakesh Singh Gadhwal, and Jyoti Arora. 2023. C-peptide as an investigatory tool for endogenous insulin secretion in Type 2 diabetes mellitus patients of Mahakaushal region. National Journal of Physiology, Pharmacy and Pharmacology, 13 (10), 2156-2159. doi:10.5455/njppp.2023.13.03120202320032023

Chicago Style

Jain, Anshul, Prabhat Kumar Budholia, Namrata Dubey, Rakesh Singh Gadhwal, and Jyoti Arora. "C-peptide as an investigatory tool for endogenous insulin secretion in Type 2 diabetes mellitus patients of Mahakaushal region." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 2156-2159. doi:10.5455/njppp.2023.13.03120202320032023

MLA (The Modern Language Association) Style

Jain, Anshul, Prabhat Kumar Budholia, Namrata Dubey, Rakesh Singh Gadhwal, and Jyoti Arora. "C-peptide as an investigatory tool for endogenous insulin secretion in Type 2 diabetes mellitus patients of Mahakaushal region." National Journal of Physiology, Pharmacy and Pharmacology 13.10 (2023), 2156-2159. Print. doi:10.5455/njppp.2023.13.03120202320032023

APA (American Psychological Association) Style

Jain, A., Budholia, . P. K., Dubey, . N., Gadhwal, . R. S. & Arora, . J. (2023) C-peptide as an investigatory tool for endogenous insulin secretion in Type 2 diabetes mellitus patients of Mahakaushal region. National Journal of Physiology, Pharmacy and Pharmacology, 13 (10), 2156-2159. doi:10.5455/njppp.2023.13.03120202320032023

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article


About National Journal of Physiology, Pharmacy and Pharmacology National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal. The journal is having open access polic ... Read more. For best results, please use Internet Explorer or Google Chrome.	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272